about
Crystal Structure and Computational Modeling of the Fab Fragment from a Protective Anti-Ricin Monoclonal AntibodyLateral Clustering of TLR3:dsRNA Signaling Units Revealed by TLR3ecd:3Fabs Quaternary StructureStructural evidence for a constrained conformation of short CDR-L3 in antibodiesAntibody modeling assessment II. Structures and modelsServerification of molecular modeling applications: the Rosetta Online Server that Includes Everyone (ROSIE)Improving the accuracy of the structure prediction of the third hypervariable loop of the heavy chains of antibodiesAntibody structure determination using a combination of homology modeling, energy-based refinement, and loop prediction.Automated Aufbau of antibody structures from given sequences using Macromoltek's SmrtMolAntibody.MoFvAb: Modeling the Fv region of antibodies.ABodyBuilder: Automated antibody structure prediction with data-driven accuracy estimation.High-accuracy modeling of antibody structures by a search for minimum-energy recombination of backbone fragmentsAntibody H3 Structure Prediction.Molecular signatures of hemagglutinin stem-directed heterosubtypic human neutralizing antibodies against influenza A viruses.Structure guided homology model based design and engineering of mouse antibodies for humanization.The origin of CDR H3 structural diversity.Defining the recognition elements of Lewis Y-reactive antibodies.Examining variable domain orientations in antigen receptors gives insight into TCR-like antibody design.LYRA, a webserver for lymphocyte receptor structural modelingImproving Loop Modeling of the Antibody Complementarity-Determining Region 3 Using Knowledge-Based RestraintsStructural diversity in a human antibody germline libraryComputer-aided antibody design.PIGSPro: prediction of immunoGlobulin structures v2Fully automated antibody structure prediction using BIOVIA tools: Validation studyNatural and man-made V-gene repertoires for antibody discovery.Clonidine inhibits anti-non-Gal IgM xenoantibody elicited in multiple pig-to-primate models.Antibody recognition of carbohydrate epitopes†.Acknowledging Errors: Advanced Molecular Replacement with Phaser.Promiscuous antibodies characterised by their physico-chemical properties: From sequence to structure and back.High-resolution modeling of antibody structures by a combination of bioinformatics, expert knowledge, and molecular simulations.Blind prediction performance of RosettaAntibody 3.0: grafting, relaxation, kinematic loop modeling, and full CDR optimization.Role of the mobility of antigen binding site in high affinity antibody elucidated by surface plasmon resonance.Shape complementarity and hydrogen bond preferences in protein-protein interfaces: implications for antibody modeling and protein-protein docking.Aggregation risk prediction for antibodies and its application to biotherapeutic development.Revisiting antibody modeling assessment for CDR-H3 loop.SAbPred: a structure-based antibody prediction server.Canonical structures of short CDR-L3 in antibodiesAutomated antibody structure prediction using Accelrys tools: results and best practices.Length-independent structural similarities enrich the antibody CDR canonical class model.Molecular basis for the antagonistic activity of an anti-CXCR4 antibody.Antibody engineering and therapeutics, The Annual Meeting of the Antibody Society: December 8-12, 2013, Huntington Beach, CA
P2860
Q27675713-EDA0574A-FB40-4766-8637-CB258817D7FDQ27679054-C9B3DD72-6B89-458D-94AA-B227B73391B0Q27689006-F4B755CB-0E7E-42F2-A929-D0D1847CC803Q27689511-73A4F427-9445-43DD-A47B-4AB354CEF14AQ28914729-273E9534-09AA-43D4-975A-75BD5A4BDA94Q29048182-461B549E-BE97-4534-AB16-C7A1DA6A46EBQ30360105-23560E15-C6F7-4C34-ABBB-3B0B07DFE37DQ30361881-6CC540AF-C339-4867-AE54-05145D39B12AQ30376735-08093F09-0F68-4298-B904-2AF3BBDA3C07Q30390296-AB4D1B60-326D-4467-AE21-78A6B488C048Q30393908-9934BFE9-7BAC-4213-A0E4-744F0219B30FQ30398990-D581D85A-4C3C-4E81-B0A7-494945660D39Q33553746-DF89DDE7-3FE1-4D2F-AB7D-456E79F400BBQ33803237-7C5371D3-62A1-488A-8F26-257B65496FC9Q35054394-C6A75755-1824-46DB-8832-8C72ED98628AQ35223746-350AB350-DAD2-48DE-85C9-91EDE93209F6Q35262045-E9D43F22-C812-4A8B-9BCA-51F6F0B654F8Q35810098-449E31CA-828E-423A-90B2-150C7C61DA1AQ36018531-96BAFABF-2F54-4418-A7A7-B2FBE5E711C0Q36025752-888B86E4-525F-41DA-8CF6-1203E434EABDQ36254449-28456CA6-23AA-4782-B579-CC5A49CEA240Q36363396-461CC8EC-CFDB-4155-9FC3-6A2AC9EB5CA9Q36380323-DC6B6BA9-4378-4D6B-A12C-CE868A125142Q36401413-00A8FF42-C0C3-4EBA-9E3B-8690D01A34E6Q36992735-A6FF75F5-197A-4548-A6F2-4357A4B5BBF3Q37840398-EFC4C94B-0E12-4350-8DE7-0354202AB464Q38749460-C49DFCD2-96B4-49D9-BC0E-8EEB475F1E6AQ38957602-94F54996-FA7E-4495-97DD-88539BCC4218Q39205310-C4CEE969-B4CA-48C0-91F0-B527E1E7C49CQ39251813-1F369B9B-19A3-4027-994D-D196E4A022AEQ39505747-181AED9F-4531-479B-91F0-56F532035375Q39788316-7EDA3775-15AA-4DDB-A72E-D1E3D39ED3F4Q41245711-1536A5B2-37B6-4BE6-B73A-9C35B6501F27Q41584601-FF001573-2B1A-4D63-B537-63A5D3AE11ECQ41723956-3494FB04-7E42-4901-A23E-21F4C209FD37Q41946585-64F7CF3C-9F36-4FEC-BBE2-B2E7CFB1048EQ42005537-680B9B58-701E-49E0-995D-E174491F63BFQ42392962-988C305E-F1F4-4F99-BC19-D1DDC78BC674Q42393773-F9C21D40-74A2-453B-93E0-B0ABC1BD42F1Q42557137-931EEA4A-600B-4837-9F2B-DBBC4D7BEA86
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Antibody modeling assessment
@ast
Antibody modeling assessment
@en
Antibody modeling assessment
@nl
type
label
Antibody modeling assessment
@ast
Antibody modeling assessment
@en
Antibody modeling assessment
@nl
prefLabel
Antibody modeling assessment
@ast
Antibody modeling assessment
@en
Antibody modeling assessment
@nl
P2093
P3181
P356
P1433
P1476
Antibody modeling assessment
@en
P2093
Francisco Hernandez-Guzman
Gary L Gilliland
Jinquan Luo
Jodi Shaulsky
Johannes Maier
Kenneth Butenhof
Kenneth Kelly
Mary Pat Beavers
Nels Thorsteinson
Paul Labute
P304
P3181
P356
10.1002/PROT.23130
P407
P577
2011-09-21T00:00:00Z